Name: UMIN ID:
Unique ID issued by UMIN | UMIN000038064 |
---|---|
Receipt number | R000042823 |
Scientific Title | EfficAcy and safety of carboPlatin, etoposide and atezOlizumab for the first-line treatment of patients with extensive-stage smaLL cell lung cancer in the real-wOrld setting. |
Date of disclosure of the study information | 2019/09/24 |
Last modified on | 2021/11/24 12:28:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/09/20 12:26:37 | ||
2 | Update | 2019/09/24 11:09:31 | Recruitment status |
|
3 | Update | 2019/09/24 11:13:46 | Date of disclosure of the study information |
|
4 | Update | 2020/09/20 09:03:46 | Recruitment status Last follow-up date |
|
5 | Update | 2021/09/21 10:44:50 | Number of participants that the trial has enrolled |
|
6 | Update | 2021/11/24 12:28:22 | Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |